Oncology Today with Dr Neil Love artwork

Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer

Oncology Today with Dr Neil Love

English - March 25, 2024 19:00 - 1 hour - 73.1 MB
Medicine Health & Fitness Science dr neil love research to practice oncology today oncology cme Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
Next Episode: Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma

Dr Seth Wander from Harvard Medical School in Boston, Massachusetts, discusses mechanisms underlying endocrine resistance in breast cancer and optimal therapeutic approaches for patients who experience disease progression while or after receiving endocrine therapy, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayEndocrineERPosmBC23).

Dr Seth Wander from Harvard Medical School in Boston, Massachusetts, discusses mechanisms underlying endocrine resistance in breast cancer and optimal therapeutic approaches for patients who experience disease progression while or after receiving endocrine therapy, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.